SARA FLOWERS: Open Payments
NPI 1972225332 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,674 in 245 payments from 13 companies in 2025. Trend: 2023 $762 · 2024 $1,883 · 2025 $3,674
Food & beverage: $2,951Travel & lodging: $723
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 14 | $985 |
| ABBVIE INC. | 37 | $402 |
| Neurocrine BioSciences, Inc. | 34 | $402 |
| E.R. Squibb & Sons, L.L.C. | 22 | $381 |
| Alkermes, Inc. | 32 | $326 |
| Otsuka America Pharmaceutical, Inc. | 38 | $305 |
| Corium, LLC | 14 | $264 |
| Lundbeck LLC | 29 | $181 |
| Axsome Therapeutics, Inc. | 7 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $144 |
Products named: SPRAVATO, REXULTI, VRAYLAR, INGREZZA, COBENFY, Azstarys, ARISTADA, Auvelity.
Industry payments across TX — which companies pay providers there.
